. Author manuscript; available in PMC: 2012 Dec 1.

Published in final edited form as: Health Phys. 2011 Dec;101(6):731–738. doi: 10.1097/HP.0b013e3182166759

Table 1.

Rhabdomyocyte survival at 48 hours. 48hr mean percent survival (±SEM) of non-IR exposed cells, as well as survival of IR-exposed cells receiving P188 alone, PEG alone, cofactor NAC alone as well as combined with P188 or MgATP and P188 with NAC and MgATP.

Treatment	Baseline	Sham-exposed	48hrs Post-Radiation (40Gy)
Treatment	0hr Control	48hr Control	No Treatment	Treatment
1mM P188	89.9% ± 1.5	83.3% ± 2.2	4.8% ± 0.6	8.1% ± 1.5^a
1mM PEG	89.9% ± 1.5	87.3% ± 3.1	6.8% ± 1.0	7.1% ± 1.4
10mM NAC	89.9% ± 1.5	85.3% ± 3.1	6.8% ± 1.0	13.4% ± 3.8^a
1mM P188, 10mM NAC	86.9% ± 2.1	88.0% ± 1.1	7.8% ± 1.9	31.2% ± 1.1^a
10mM NAC, 0.1mM MgATP	86.9% ± 2.1	82.5% ± 1.2	5.5% ± 1.6	19.9% ± 1.7^a
1mM P188, 10mM NAC, 0.1mM MgATP	86.9% ± 2.1	81.7% ± 1.0	7.2% ± 1.4	29.5% ± 3.0^a

Results are significantly different than irradiated, untreated samples